Barbara Ann Jacobsmeyer - Jul 1, 2022 Form 4/A - Amendment Insider Report for Enhabit, Inc. (EHAB)

Role
President and CEO, Director
Signature
/s/ Sarah Braley, Attorney in Fact
Stock symbol
EHAB
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/1/2023, 04:06 PM
Date Of Original Report
Jul 6, 2022
Previous filing
Jun 17, 2022
Next filing
Aug 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EHAB Common Stock Other $0 +18.9K $0.00 18.9K Jul 1, 2022 Direct F1
transaction EHAB Common Stock Other $0 +24K +127.27% $0.00 42.9K Jul 1, 2022 Direct F2
transaction EHAB Common Stock Other $0 +103K +238.93% $0.00 145K Jul 1, 2022 Direct F3
transaction EHAB Common Stock Award $0 +132K +90.71% $0.00 277K Jul 1, 2022 Direct
transaction EHAB Common Stock Award $0 +47.8K +17.24% $0.00 325K Jul 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EHAB Employee Stock Option (Right to Buy) Other $0 +19.2K $0.00 19.2K Jul 1, 2022 Common Stock 19.2K $17.13 Direct F4
transaction EHAB Employee Stock Option (Right to Buy) Other $0 +29.9K $0.00 29.9K Jul 1, 2022 Common Stock 29.9K $21.83 Direct F4
transaction EHAB Employee Stock Option (Right to Buy) Other $0 +35.1K $0.00 35.1K Jul 1, 2022 Common Stock 35.1K $25.88 Direct F4
transaction EHAB Employee Stock Option (Right to Buy) Other $0 +42.5K $0.00 42.5K Jul 1, 2022 Common Stock 42.5K $31.06 Direct F4, F5
transaction EHAB Employee Stock Option (Right to Buy) Other $0 +41K $0.00 41K Jul 1, 2022 Common Stock 41K $32.62 Direct F4, F6
transaction EHAB Employee Stock Option (Right to Buy) Other $0 +54.6K $0.00 54.6K Jul 1, 2022 Common Stock 54.6K $26.94 Direct F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the spin-off of Enhabit, Inc. ("Enhabit") by Encompass Health Corporation ("Encompass") on July 1, 2022, Encompass distributed all of the issued and outstanding shares of Enhabitcommon stock to Encompass stockholders (the "Distribution"). Encompass stockholders received one share of Enhabit common stock for every two shares of Encompass common stock held as of the close ofbusiness on June 24, 2022. The number of shares of Enhabit common stock reported reflects the number of shares of Enhabit common stock received pursuant to the Distribution.
F2 Restricted stock awards originally granted by Encompass were converted to Enhabit restricted stock awards on the date of the Distribution. The restricted stock awards have vesting dates consistent with the original awards from Encompass.
F3 Performance share units originally granted by Encompass were converted to Enhabit restricted stock units on the date of the Distribution. The restricted stock units have vesting dates consistent with the original awards from Encompass.
F4 In connection with the spin-off of Enhabit by Encompass and pursuant to the Employee Matters Agreement between Enhabit and Encompass, on the date of Distribution, each outstanding option to purchase stock options originally granted by Encompass were converted to Enhabit stock options on the date of Distribution.
F5 The converted Enhabit stock option has the same vesting schedule as the original Encompass stock option, which vested as to one-third of the shares on March 2, 2021, the first anniversary of the date of grant, and vests as to one-third of the shares annually thereafter.
F6 The converted Enhabit stock option has the same vesting schedule as the original Encompass stock option, which vested as to one-third of the shares on March 2, 2022, the first anniversary of the date of grant, and vests as to one-third of the shares annually thereafter.
F7 The converted Enhabit stock option has the same vesting schedule as the original Encompass stock option, which will vest as to one-third of the shares on March 1, 2023, the first anniversary of the date of grant, and vests as to one-third of the shares annually thereafter.